CD8A and head and neck squamous cell carcinoma: Moreover, in head and neck squamous cell carcinoma (HNSCC), therapeutic inhibition of MYC promoted intrinsic anti-tumor immune responses through the cGAS-STING signaling pathway, and CD8+ T-cell infiltration of HNSCC in vivo (113).